Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Schizophrenia

In brief

The primary objective of the study is to evaluate changes in weight short and long term with bifeprunox and quetiapine. Study participation for the subject is 57 weeks.

Key facts

Study ID

NCT00396214

Run by

Solvay Pharmaceuticals

People needed

83

Starts

2007-04-01

Expected to finish

2008-01-01

Last updated by the study team

2008-06-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Schizophrenia
• 18-65 years
• No hospitalization for an exacerbation of schizophrenia within two months prior to screening and during the screening period

You may not qualify if…

• Subjects who are acutely psychotic or subjects with current Axis I primary psychiatric diagnosis other than schizophrenia
• At significant risk of suicide, and the potential for violent behavior (likely to harm themselves or others) based on history

Where it is running

• Site 333 — Anaheim, California, United States
• Site 323 — Cerritos, California, United States
• Site 374 — Costa Mesa, California, United States
• Site 326 — Culver City, California, United States
• Site 300 — Glendale, California, United States
• Site 343 — Long Beach, California, United States
• Site 356 — Los Angeles, California, United States
• Site 367 — Los Angeles, California, United States
• Site 322 — Oceanside, California, United States
• Site 316 — Pasadena, California, United States
• Site 302 — Sacramento, California, United States
• Site 315 — San Diego, California, United States
• Site 331 — San Diego, California, United States
• Site 340 — San Diego, California, United States
• Site 311 — Santa Ana, California, United States
• Site 336 — Santa Ana, California, United States
• Site 344 — Torrance, California, United States
• Site 318 — Denver, Colorado, United States
• Site 371 — Darien, Connecticut, United States
• Site 358 — Hartford, Connecticut, United States
• Site 360 — New Britain, Connecticut, United States
• Site 317 — Hialeah, Florida, United States
• Site 362 — Largo, Florida, United States
• Site 327 — Miami, Florida, United States
• Site 313 — Anaheim, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.